Allo-depleted lymphocyte infusion
ALODEPLETE
Phase 1 other terminated
Quick answer
Allo-depleted lymphocyte infusion for Transplant-Related Hematologic Malignancy is a Phase 1 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Transplant-Related Hematologic Malignancy
- Phase
- Phase 1
- Modality
- other
- Status
- terminated